Cancer statistics, 2012

Cited by (1,032)

Items 201–300 of 1,032

1. Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
   Martin Pichler, Georg C. Hutterer, Caroline Stoeckigt, Thomas F. Chromecki, Tatjana Stojaković, Silvia Verena Golbeck, Katharina Eberhard, Armin Gerger, Sebastian Mannweiler, Karl Pummer et al. · 2013 · British Journal of Cancer
2. Castration-Resistant Prostate Cancer: AUA Guideline
   Michael S. Cookson, Bruce J. Roth, Philipp Dahm, Christine A. Engstrom, Stephen J. Freedland, Maha Hussain, Daniel Wei Lin, William Thomas Lowrance, Mohammad Hassan Murad, William K. Oh et al. · 2013 · The Journal of Urology
3. Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial
   Nanda Horeweg, Carlijn M. van der Aalst, Erik Thunnissen, Kristiaan Nackaerts, Carla Weenink, Harry J.M. Groen, Jan‐Willem J. Lammers, Joachim G.J.V. Aerts, Ernst T. Scholten, Joost van Rosmalen et al. · 2013 · American Journal of Respiratory and Critical Care Medicine
4. Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature
   Faya Martin Millimouno, Jia Dong, Yang Liu, Jiang Li, Xiaomeng Li · 2014 · Cancer Prevention Research
5. The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship
   Maximilian Weniger, Kim C. Honselmann, Andrew Scott Liss · 2018 · Cancers
6. CKD and the Risk of Incident Cancer
   William Thomas Lowrance, Juan D. Ordoñez, Natalia V. Udaltsova, Paul Russo, Alan S. Go · 2014 · Journal of the American Society of Nephrology
7. MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
   Lorena Fontán, Chenghua Yang, Venkataraman Kabaleeswaran, Laurent Volpon, Michael J. Osborne, Elena Beltrán, M. A. Moro García, Leandro C. A. Cerchietti, Rita Shaknovich, Shao Ning Yang et al. · 2012 · Cancer Cell
8. Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
   Gaixia He, Henghui Zhang, Jinxue Zhou, Beibei Wang, Yanhui Chen, Yaxian Kong, Xingwang Xie, Xueyan Wang, Ran Fei, Lai Wei et al. · 2015 · Journal of Experimental & Clinical Cancer Research
9. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)
   Eric J. Duell, Ersilia Lucenteforte, Sara H. Olson, Paige M. Bracci, Dali Li, Harvey A. Risch, Debra T. Silverman, Bu‐Tian Ji, Steve Gallinger, Elizabeth A. Holly et al. · 2012 · Annals of Oncology
10. Effect of a Patient and Clinician Communication-Priming Intervention on Patient-Reported Goals-of-Care Discussions Between Patients With Serious Illness and Clinicians
    Jared Randall Curtis, Lois Downey, Anthony L. Back, Elizabeth L. Nielsen, Sudiptho R. Paul, Alexandria Z. Lahdya, Patsy D. Treece, Priscilla Armstrong, Ronald Peck, Ruth A. Engelberg · 2018 · JAMA Internal Medicine
11. A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer
    Shin Nishiumi, Takashi Kobayashi, Atsuki Ikeda, Tomoo Yoshie, Megumi Kibi, Yoshihiro Izumi, Tatsuya Okuno, Nobuhide Hayashi, Seiji Kawano, Tadaomi Takenawa et al. · 2012 · PLoS ONE
12. Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment
    Kim-Fuchs, Corina, Le, Caroline P., Pimentel, Matthew A., Shackleford, David, Ferrari, Davide, Angst, Eliane, Hollande, Frédéric, Sloan, Erica K. · 2014 · Brain, Behavior, and Immunity
13. Curcumin use in pulmonary diseases: State of the art and future perspectives
    Diana Lelli, Amirhossein Sahebkar, Thomas Patrick Johnston, Claudio Pedone · 2016 · Pharmacological Research
14. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
    Berit Maria Müller, Lisa Jana, Atsuko Kasajima, Annika Lehmann, Judith Prinzler, Jan Budczies, Klaus‐Jürgen Winzer, Manfred Dietel, Wilko Weichert, Carsten Denkert · 2013 · BMC Cancer
15. Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS
    Nishant Agrawal, Yuchen Jiao, Mark Sausen, Rebecca J. Leary, Chetan Bettegowda, Nicholas Jason Roberts, Sheetal Bhan, Allen S. Ho, Zubair Hanif Khan, Justin A. Bishop et al. · 2012 · The Journal of Clinical Endocrinology & Metabolism
16. Skin cancer detection: Applying a deep learning based model driven architecture in the cloud for classifying dermal cell images
    Mohammad Ali Kadampur, Sulaiman Alriyaee · 2019 · Informatics in Medicine Unlocked
17. Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients
    Campbell, Tavis, Garland, Sheila, Johnson, Jillian, Savard, Josee, Gehrman, Philip, Perlis, Michael, Carlson, Linda · 2014 · Neuropsychiatric Disease and Treatment
18. Survival Outcome After Stereotactic Body Radiation Therapy and Surgery for Stage I Non-Small Cell Lung Cancer: A Meta-Analysis
    Xiangpeng Zheng, Matthew J. Schipper, KM Kidwell, Jules Lin, Rishindra Mamidi Reddy, Yanping Ren, Andrew C. Chang, Fanzhen Lv, Mark B. Orringer, Feng‐Ming Kong · 2014 · International Journal of Radiation Oncology*Biology*Physics
19. Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
    Shili Xu, Alexey N. Butkevich, Roppei Yamada, Yu Zhou, Bikash Debnath, Roger Duncan, Ebrahim Zandi, Nicos A. Petasis, Nouri Neamati · 2012 · Proceedings of the National Academy of Sciences
20. Systemic treatments for metastatic cutaneous melanoma
    Sandro Pasquali, Andreas V. Hadjinicolaou, Vanna Chiarion‐Sileni, Carlo Riccardo Rossi, Simone Mocellin M. D · 2018 · Cochrane Database of Systematic Reviews
21. Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells
    Zhiyuan Ma, David J. Vocadlo, Keith Vosseller · 2013 · Journal of Biological Chemistry
22. A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice
    Bincy Philip, Christina Lynn Roland, Jarosław Daniluk, Yan Liu, Deyali Chatterjee, Sobeyda Gomez, Baoan Ji, Haojie Huang, Huamin Wang, Jason B. Fleming et al. · 2013 · Gastroenterology
23. DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
    John Thomas Poirier, Eric E. Gardner, Nick Connis, Andre Luis Moreira, Elisa de Stanchina, Christine L. Hann, Charles M. Rudin · 2015 · Oncogene
24. Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial
    Toni K. Choueiri, David J. Figueroa, André Poisl Fay, Sabina Signoretti, Yuan Liu, Robert Gagnon, Keith C. Deen, Christopher F Carpenter, Peter Benson, Thai H. Ho et al. · 2014 · Clinical Cancer Research
25. Quantitative Analysis of Multiparametric Prostate MR Images: Differentiation between Prostate Cancer and Normal Tissue and Correlation with Gleason Score—A Computer-aided Diagnosis Development Study
    Yahui Peng, Yulei Jiang, Cheng Yang, Jeremy Bancroft Brown, Tatjana Antic, Ila Sethi, Christine Schmid‐Tannwald, Maryellen Lissak Giger, Scott E. Eggener, Aytekin Oto · 2013 · Radiology
26. Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines
    James Lloyd Mohler, Andrew J. Armstrong, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony Victor D'Amico, James Andrew Eastham, Charles A. Enke, Thomas Farrington, Celestia S. Higano et al. · 2012 · Journal of the National Comprehensive Cancer Network
27. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
    Sandeep Singh, Jose Gilberto Trevino, Namrata Bora-Singhal, Domenico Coppola, Eric B. Haura, Soner Altiok, Srikumar Chellappan · 2012 · Molecular Cancer
28. The Role of Inflammation in Lung Cancer
    Mónica Patrícia Gomes, Ana Luísa Teixeira, Ana Coelho, António Araújo, Rui Medeiros · 2014 · Advances in experimental medicine and biology
29. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients
    Basem N. Azab, Neeraj Nailesh Shah, Jared M. Radbel, Pamela Tan, Vijaya Raj Bhatt, Steven Vonfrolio, Ayman Habeshy, Antonio I. Picon, Scott W. Bloom · 2013 · Medical Oncology
30. Robust ICG Theranostic Nanoparticles for Folate Targeted Cancer Imaging and Highly Effective Photothermal Therapy
    Mingbin Zheng, Pengfei Zhao, Zhenyu Luo, Ping Gong, Cuifang Zheng, Pengfei Zhang, Caixia Yue, Duyang Gao, Yifan Ma, Lintao Cai · 2014 · ACS Applied Materials & Interfaces
31. CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer
    Albrecht Neeße, Kristopher K. Frese, Tashinga E. Bapiro, Tomoaki Nakagawa, Mark D. Sternlicht, Todd W. Seeley, Christian P. Pilarsky, Duncan Ian Jodrell, Suzanne M. Spong, David Arthur Tuveson · 2013 · Proceedings of the National Academy of Sciences
32. Stem cell dynamics in homeostasis and cancer of the intestine
    Louis Vermeulen, Hugo J.G. Snippert · 2014 · Nature reviews. Cancer
33. Optimizing Adequacy of Bowel Cleansing for Colonoscopy: Recommendations From the US Multi-Society Task Force on Colorectal Cancer
    David A. Johnson, Alan N. Barkun, Larry B. Cohen, Jason A. Dominitz, Tonya R. Kaltenbach, Myriam Martel, Douglas J. Robertson, Clement Richard Boland, Frances M. Giardello, David A. Lieberman et al. · 2014 · The American Journal of Gastroenterology
34. Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer
    Michael Ian D'Angelica, Camilo Correa‐Gallego, Philip B. Paty, Andrea Cercek, Alexandra N. Gewirtz, Joanne F. Chou, Marinella Capanu, T. Peter Kingham, Yuman Fong, Ronald P. DeMatteo et al. · 2014 · Annals of Surgery
35. Clear cell carcinoma of the ovary: A review of the literature
    Marcela G.del Carmen, Michael J. Birrer, John O. Schorge · 2012 · Gynecologic Oncology
36. Classification of mitocans, anti-cancer drugs acting on mitochondria
    Jiřı́ Neužil, Lan‐Feng Dong, Jakub Rohlena, Jaroslav Truksa, Stephen John Ralph · 2012 · Mitochondrion
37. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy
    Ab A. Aaldriks, Lydia G. van der Geest, Erik J. Giltay, Saskia le Cessie, Johanneke E.A. Portielje, Bea C. Tanis, Johan W.R. Nortier, Ed Maartense · 2013 · Journal of Geriatric Oncology
38. Patients With Heart Failure Have an Increased Risk of Incident Cancer
    Tal Hasin, Yariv Gerber, Sheila M McNallan, Susan A. Weston, Sudhir S. Kushwaha, Timothy J. Nelson, James R. Cerhan, Veronique Lee Roger · 2013 · Journal of the American College of Cardiology
39. Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
    Audrey Mauguen, Jean‐Pierre Pignon, Sarah Burdett, Caroline Domerg, David J. Fisher, Rebecca Paulus, Samithra J Mandrekar, Chandra Prakash Belani, Frances A. Shepherd, Tim G Eisen et al. · 2013 · The Lancet Oncology
40. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles
    Changyang Gong, Senyi Deng, Qinjie Wu, Mingli Xiang, Xiawei Wei, Ling Li, Xiang Gao, Bilan Wang, Lu Sun, Yishan Chen et al. · 2012 · Biomaterials
41. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma
    Jingting Wang, Yandong Zhou, Jianguang Lu, Yanan Sun, Hui Xiao, Ming Liu, Linli Tian · 2014 · Medical Oncology
42. Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial
    Paul F. Schellhammer, Gerald W. Chodak, James Boyd Whitmore, Robert Brownell Sims, Mark Walter Frohlich, Philip W. Kantoff · 2013 · Urology
43. Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data Base
    Phillip J. Gray, Stacey A. Fedewa, William U. Shipley, Jason Alexander Efstathiou, Chun Chieh Lin, Anthony Laurence Zietman, Katherine S. Virgo · 2012 · European Urology
44. Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
    Marlo A. Blazer, Christina Sing-Ying Wu, Richard M. Goldberg, Gary S. Phillips, Carl Richard Schmidt, Peter Muscarella, Evan John Wuthrick, Terrence M. Williams, Joshua Reardon, Edwin Christopher Ellison et al. · 2014 · Annals of Surgical Oncology
45. U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
    Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas, Robert C. Kane, Kallappa M. Koti, Mark D. Rothmann, Bahru A. Habtemariam, Julie M. Bullock, Jeffrey D. Bray, Jessica J. Hawes et al. · 2013 · Clinical Cancer Research
46. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promote s NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transition
    Ming Sun, X-H Liu, K-H Lu, F.F. Nie, R Xia, Renyi Kong, JS Yang, T-p Xu, Y-W Liu, Y-F Zou et al. · 2014 · Cell Death and Disease
47. Aberrant PSA glycosylation—a sweet predictor of prostate cancer
    Sarah Gilgunn, Paul J. Conroy, Radka Saldova, Pauline Mary Rudd, Richard J O’Kennedy · 2013 · Nature Reviews Urology
48. Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer
    Kyoko Okamura, Koichi Takayama, Miiru Izumi, Taishi Harada, Kazuto Furuyama, Yoichi Nakanishi · 2013 · Lung Cancer
49. Thoracoscopic Lobectomy Has Increasing Benefit in Patients With Poor Pulmonary Function
    DuyKhanh P. Ceppa, Andrzej Stanislaw Kosinski, Mark F. Berry, Betty Caroline Tong, David H. Harpole, John D. Mitchell, Thomas Anthony D’Amico, Mark W. Onaitis · 2012 · Annals of Surgery
50. The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing
    Feng-Yang Zong, Xing Fu, Wenjuan Wei, Ya-Ge Luo, Monika Heiner, Lijuan Cao, Zhaoyuan Fang, Rong Fang, Daru Lu, Hongbin Ji et al. · 2014 · PLoS Genetics
51. Diagnostic aids for detection of oral precancerous conditions
    Diana V. Messadi · 2013 · International Journal of Oral Science
52. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
    Dan Wang, Yang Li, Weina Yu, Qian Wu, Jingyao Lian, Feng Li, Shasha Liu, Aitian Li, Zhiang He, Jinbo Liu et al. · 2019 · Journal for ImmunoTherapy of Cancer
53. Breastfeeding and Childhood Leukemia Incidence
    Efrat L. Amitay, Lital Keinan‐Boker · 2015 · Archives of Pediatrics and Adolescent Medicine
54. Obesity and cancer pathogenesis
    Nathan A. Berger · 2014 · Annals of the New York Academy of Sciences
55. HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction
    Xing Chen, Chenggang Clarence Yan, Xu Zhang, Zhu‐Hong You, Yu‐An Huang, Guiying Yan · 2016 · Oncotarget
56. African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?
    Debasish Sundi, Ashley Evan Ross, Elizabeth B. Humphreys, Misop Han, Alan Wayne Partin, H. Ballentine Carter, Edward Matthew Schaeffer · 2013 · Journal of Clinical Oncology
57. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
    Jiaqiao Fan, Mengfei Wang, Hailong Chen, Dong Shang, Jugal Kishore Das, Jianxun Jim Song · 2020 · Molecular Cancer
58. Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis
    Wei‐Chih Liao, Kuo‐Liong Chien, Yulin Lin, Ming‐Shiang Wu, Jaw‐Town Lin, Hsiu‐Po Wang, Yu‐Kang Tu · 2013 · The Lancet Oncology
59. Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
    Michele Cioffi, Sara Maria David Trabulo, Manuel M. Hidalgo, Eithne Costello, William Greenhalf, Mert Erkan, Jorg H. Kleeff, Bruno Sáinz, Christopher Heeschen · 2015 · Clinical Cancer Research
60. A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy
    Liheng Che, Jingwen Liu, Jian-Ping Huo, Rong Luo, Rui-Ming Xu, Cai He, Yu-Qing Li, Aijun Zhou, Piao Huang, Yongyu Chen et al. · 2021 · Cell Discovery
61. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis
    Wei Yue, James D. Yager, Ji-Ping Wang, Eldon R. Jupe, Richard J. Santen · 2012 · Steroids
62. Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
    Olivier Huillard, Olivier Mir, Michaël Peyromaure, Camille Tlemsani, Julie Giroux, Pascaline Boudou, Stanislas Ropert, Nicolas Barry Delongchamps, Marc Zerbib, François Goldwasser · 2013 · British Journal of Cancer
63. The Association between Obesity and Cancer Risk: A Meta-Analysis of Observational Studies from 1985 to 2011
    Maureen Dobbins, Kara DeCorby, Bernard C. K. Choi · 2013 · ISRN Preventive Medicine
64. Dietary Lycopene, Angiogenesis, and Prostate Cancer: A Prospective Study in the Prostate-Specific Antigen Era
    Ke Zu, Lorelei Ann Mucci, BERNARD A. ROSNER, Steven K. Clinton, Massimo F. Loda, Meir J. Stampfer, Edward L. Giovannucci · 2014 · JNCI Journal of the National Cancer Institute
65. Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
    Klaus Griewank, Henrike Westekemper, Rajmohan Murali, Monika Mach, Bastian Schilling, Thomas Wiesner, Tobias T. Schimming, Elisabeth Livingstone, Antje Sucker, Florian Grabellus et al. · 2013 · Clinical Cancer Research
66. Dual-Modality Photoacoustic and Ultrasound Imaging System for Noninvasive Sentinel Lymph Node Detection in Patients with Breast Cancer
    Alejandro Garcia‐Uribe, Todd N. Erpelding, Arie Krumholz, Haixin Ke, Konstantin Maslov, Catherine M. Appleton, Julie A. Margenthaler, Lihong V. Wang · 2015 · Scientific Reports
67. Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
    Grant Duncan Stewart, Leander Van Neste, Philippe Delvenne, P. Delrée, Agnès Delga, S. Alan McNeill, Marie O’Donnell, James Clark, Wim Van Criekinge, Joseph W. Bigley et al. · 2012 · The Journal of Urology
68. Increase in the Incidence of Differentiated Thyroid Carcinoma in Children, Adolescents, and Young Adults: A Population-Based Study
    Lucas B. Vergamini, A. Lindsay Frazier, Fernanda L. Abrantes, Karina Braga Ribeiro, Carlos Rodriguez Galindo · 2014 · The Journal of Pediatrics
69. Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes
    Roberto Gomez-Casal, Chitralekha Bhattacharya, Nandita Ganesh, Lisa Bailey, Per H. Basse, Michael K. Gibson, Michael W. Epperly, Vera V. Levina · 2013 · Molecular Cancer
70. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer
    Lian Zhao, Haibo Yu, Shuijing Yi, Xiaowei Peng, Peng Su, Zhiming Xiao, Rui Liu, Anliu Tang, Xiayu Li, Fen Liu et al. · 2016 · Oncotarget
71. A Systematic Review and Meta-analysis of Tobacco Use and Prostate Cancer Mortality and Incidence in Prospective Cohort Studies
    Farhad Islami, Daniel Martins Moreira, Paolo Boffetta, Stephen J. Freedland · 2014 · European Urology
72. Curcumin in various cancers
    Adeeb Shehzad, Jaetae Lee, Young Sup Lee · 2013 · BioFactors
73. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200
    Miharu Kobayashi, Carlos Salomón, Jorge Tapia, Sebastian Enrique Illanes, Murray David Mitchell, Gregory Edward Rice · 2014 · Journal of Translational Medicine
74. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1
    P. Wang, L Chen, Jialong Zhang, H Chen, Jie Fan, Kaining Wang, Jian‐Min Luo, Zhen Chen, Zhefeng Meng, Liang Liu · 2013 · Oncogene
75. Reply to Increased cancer burden among pesticide applicators and others due to pesticide exposure
    Michael C.R. Alavanja, Matthew K. Ross, Matthew R. Bonner · 2013 · CA A Cancer Journal for Clinicians
76. Platinum nanoparticles for the photothermal treatment of Neuro 2A cancer cells
    M. Manikandan, Nazim Hasan, Hui‐Fen Wu · 2013 · Biomaterials
77. Adherence to Treatment Guidelines for Ovarian Cancer as a Measure of Quality Care
    Robert E. Bristow, Jenny J. Chang, Argyrios Ziogas, Hoda Anton‐Culver · 2013 · Obstetrics and Gynecology
78. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer
    Wenjin Xu, Imtiaz Ahmad Siddiqui, Minakshi Nihal, Srikanth Pilla, Kimberly A. Rosenthal, Hasan Mukhtar, Shaoqin Gong · 2013 · Biomaterials
79. Tumor MicroRNA Expression Profiling Identifies Circulating MicroRNAs for Early Breast Cancer Detection
    Nerea Matamala, María Teresa Vargas, Ricardo González‐Cámpora, Rebeca Miñambres, José Ignacio Arias, Primitiva Menéndez, Eduardo Andrés‐León, Gonzalo Goméz-López, Kira Yanowsky, Julio Calvete-Candenas et al. · 2015 · Clinical Chemistry
80. Initiation of puberty in mice following decellularized ovary transplant
    Monica M. Laronda, Adam E. Jakus, Kelly A. Whelan, Jason A. Wertheim, Ramille N. Shah, Teresa K. Woodruff · 2015 · Biomaterials
81. Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
    Marius Distler, Daniela Ellen Aust, Jürgen Weitz, Christian P. Pilarsky, Robert Grützmann · 2014 · BioMed Research International
82. Tolerance of the Human Kidney to Isolated Controlled Ischemia
    Dipen J. Parekh, Joel M. Weinberg, Barbara Ercole, Kathleen C. Torkko, William Hilton, MICHAEL R. BENNETT, Prasad Devarajan, Manjeri A. Venkatachalam · 2013 · Journal of the American Society of Nephrology
83. Follow-up and Surveillance of the Patient With Lung Cancer After Curative-Intent Therapy
    Henri G. Colt, Septimiu Dan Murgu, Robert J. Korst, Christopher G. Slatore, Michael Unger, Sílvia Quadrelli · 2013 · CHEST Journal
84. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition
    Ming Sun, Xiang-hua Liu, Keming Wang, Fengqi Nie, Rong Kong, Jinsong Yang, Rui Xia, Tongpeng Xu, Fei-Yan Jin, Zhijun Liu et al. · 2014 · Molecular Cancer
85. Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study
    Yanbin Chen, Chuanyong Mu, Jian‐An Huang · 2012 · Tumori Journal
86. Causes of death in long‐term survivors of head and neck cancer
    Shrujal S. Baxi, Laura C. Pinheiro, Sujata M. Patil, David G. Pfister, Kevin Charles Oeffinger, Elena B. Elkin · 2014 · Cancer
87. Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development
    Stephen Sunghan Yoo, Timothy J. Jorgensen, Ann R. Kennedy, John D. Boice, Alla Shapiro, Tom C. Hu, Brian R. Moyer, Marcy B. Grace, Gary J. Kelloff, Michael Felix Fenech et al. · 2014 · Journal of Radiological Protection
88. Challenges and Possible Solutions to Colorectal Cancer Screening for the Underserved
    Samir Gupta, Daniel Andrew Sussman, Chyke A. Doubeni, D. S. Anderson, L. Day, Amar R. Deshpande, B. Joseph Elmunzer, Adeyinka O. Laiyemo, J. Mendez, Ma Somsouk et al. · 2014 · JNCI Journal of the National Cancer Institute
89. Trends in Prostate Cancer in the United States
    Otis W. Brawley · 2012 · JNCI Monographs
90. Advanced-stage pancreatic cancer: therapy options
    Jens Werner, Stephanie Elisabeth Combs, Christoph Springfeld, Werner Hartwig, Thilo Hackert, Markus Wolfgang Büchler · 2013 · Nature Reviews Clinical Oncology
91. Technical Factors that Affect Anastomotic Integrity Following Esophagectomy: Systematic Review and Meta-analysis
    Sheraz Rehan Markar, Shobhit Arya, Alan Karthikesalingam, George Bushra Hanna · 2013 · Annals of Surgical Oncology
92. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis
    Zhenghong Xu, Srinivas Ramishetti, Yu-Cheng Tseng, Shutao Guo, Yuhua Wang, Leaf Huang · 2013 · Journal of Controlled Release
93. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
    Sheraz Rehan Markar, Caroline Gronnier, Alain Duhamel, Arnaud Pasquer, Jérémie Thereaux, M. Chalret du Rieu, Jérémie H. Lefèvre, Kathleen Turner, Guillaume Luc, C. Mariette · 2015 · Journal of Clinical Oncology
94. Nanoscaled Poly( l -glutamic acid)/Doxorubicin-Amphiphile Complex as pH-responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer
    Mingqiang Li, Wantong Song, Zhaohui Tang, Shixian Lv, Lin Lin, Hai Yang Sun, Quanshun Li, Yan Yang, Hua Hong, Xuesi Chen · 2013 · ACS Applied Materials & Interfaces
95. Screening for Hepatocellular Carcinoma in Chronic Liver Disease
    Devan L. Kansagara, Joel Papak, Amirala S. Pasha, Maya Elin O'Neil, Michele Freeman, Rose Relevo, Ana Romàn Quiñones, Makalapua L. Motu’apuaka, Janice H. Jou · 2014 · Annals of Internal Medicine
96. An integrative view on sex differences in brain tumors
    Tao Sun, Anya Plutynski, Stacey Ward, Joshua B. Rubin · 2015 · Cellular and Molecular Life Sciences
97. MoS2-based nanocomposites for cancer diagnosis and therapy
    Jian-Ling Wang, Lihua Sui, Jia Huang, Lu Miao, Yubing Nie, Kuansong Wang, Zhi‐Chun Yang, Qiong Huang, Xue Gong, Yayun Nan et al. · 2021 · Bioactive Materials
98. Nisin ZP, a Bacteriocin and Food Preservative, Inhibits Head and Neck Cancer Tumorigenesis and Prolongs Survival
    Kamarajan, Pachiyappan, Hayami, Takayuki, Matte, Bibiana, Liu, Yang, Danciu, Theodora, Ramamoorthy, Ayyalusamy, Worden, Francis, Kapila, Sunil, Kapila, Yvonne · 2015 · PLOS ONE
99. Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer
    Vassiliki A. Papadimitrakopoulou · 2012 · Journal of Thoracic Oncology
100. Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study
     Massimo Lazzeri, Alexander Haese, Alexandre DE LA TAILLE, Joan Palou, Tom McNicholas, Giovanni Lughezzani A, Vincenzo Scattoni, Vittorio Bini, Massimo Freschi, Amy N. Sussman et al. · 2013 · European Urology